Natural compounds with DPP-4 inhibitory effects

Implications for the treatment of diabetes

Habib Yaribeygi, Stephen Atkin, Amirhossein Sahebkar

Research output: Contribution to journalReview article

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.

Original languageEnglish
JournalJournal of Cellular Biochemistry
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Dipeptidyl Peptidase 4
Medical problems
Hypoglycemia
Dipeptidyl-Peptidase IV Inhibitors
Glucagon-Like Peptide 1
Therapeutics
Nutrition
Blood Glucose
Diet
Food
Degradation

Keywords

  • alkaloids
  • diabetes mellitus
  • dipeptidyl peptidase-4 inhibitors
  • glycosides
  • herbal compounds
  • phenol

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Natural compounds with DPP-4 inhibitory effects : Implications for the treatment of diabetes. / Yaribeygi, Habib; Atkin, Stephen; Sahebkar, Amirhossein.

In: Journal of Cellular Biochemistry, 01.01.2019.

Research output: Contribution to journalReview article

@article{e530692edbb84677bc2eded21b718e35,
title = "Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetes",
abstract = "Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.",
keywords = "alkaloids, diabetes mellitus, dipeptidyl peptidase-4 inhibitors, glycosides, herbal compounds, phenol",
author = "Habib Yaribeygi and Stephen Atkin and Amirhossein Sahebkar",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/jcb.28467",
language = "English",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Natural compounds with DPP-4 inhibitory effects

T2 - Implications for the treatment of diabetes

AU - Yaribeygi, Habib

AU - Atkin, Stephen

AU - Sahebkar, Amirhossein

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.

AB - Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.

KW - alkaloids

KW - diabetes mellitus

KW - dipeptidyl peptidase-4 inhibitors

KW - glycosides

KW - herbal compounds

KW - phenol

UR - http://www.scopus.com/inward/record.url?scp=85061933454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061933454&partnerID=8YFLogxK

U2 - 10.1002/jcb.28467

DO - 10.1002/jcb.28467

M3 - Review article

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

ER -